CTOs on the Move

GN Resound

www.gnresound.com

 
GN ReSound is the undisputed technology leader in the global hearing instrument market and is one of several divisions of GN Great Nordic. To learn more about our parent company, Great Nordic, please click on the link below.
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million
  • www.gnresound.com
  • 8001 E Bloomington Fwy
    Minneapolis, MN USA 55420
  • Phone: 952.769.8000

Executives

Name Title Contact Details

Similar Companies

Hemispherx Biopharma

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.

American Medical Response (AMR)

American Medical Response (AMR) is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthy Environments

Healthy Environments is a Mooresville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

On Belay Health Solutions

On Belay Health Solutions is a company that supports independent primary care physicians in their quest to access meaningful value-based contracts and provides the clinical support necessary to succeed and maintain their independence.

University Emergency Physicians

University Emergency Physicians is a Cincinnati, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.